Jackson Creek Investment Advisors LLC Takes Position in AdaptHealth Corp. (NASDAQ:AHCO)

Jackson Creek Investment Advisors LLC bought a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 135,198 shares of the company's stock, valued at approximately $1,466,000. Jackson Creek Investment Advisors LLC owned approximately 0.10% of AdaptHealth at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bailard Inc. purchased a new stake in AdaptHealth in the first quarter valued at approximately $322,000. Victory Capital Management Inc. grew its holdings in AdaptHealth by 39.4% in the first quarter. Victory Capital Management Inc. now owns 296,250 shares of the company's stock valued at $3,211,000 after purchasing an additional 83,731 shares during the last quarter. New York State Common Retirement Fund boosted its stake in shares of AdaptHealth by 10.3% during the first quarter. New York State Common Retirement Fund now owns 836,773 shares of the company's stock valued at $9,071,000 after acquiring an additional 78,211 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of AdaptHealth by 54.2% during the first quarter. Envestnet Asset Management Inc. now owns 70,919 shares of the company's stock valued at $769,000 after acquiring an additional 24,942 shares during the last quarter. Finally, Palisade Capital Management LP boosted its stake in shares of AdaptHealth by 12.3% during the first quarter. Palisade Capital Management LP now owns 2,711,142 shares of the company's stock valued at $29,389,000 after acquiring an additional 297,268 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

Analyst Ratings Changes

AHCO has been the topic of several analyst reports. Royal Bank Of Canada dropped their price objective on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. Truist Financial dropped their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Trading Down 0.8%

AHCO stock traded down $0.07 during trading on Monday, reaching $9.15. The company had a trading volume of 733,009 shares, compared to its average volume of 1,334,747. The business has a 50 day moving average of $8.99 and a 200 day moving average of $9.39. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.90. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.29 and a quick ratio of 1.07. The company has a market cap of $1.23 billion, a P/E ratio of 16.05, a PEG ratio of 1.07 and a beta of 1.63.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.